ID

26011

Descripción

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00089323

Link

https://clinicaltrials.gov/show/NCT00089323

Palabras clave

Versiones (2)
  1. 2/10/17 2/10/17 -
  2. 4/10/17 4/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

4 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00089323

Inglés

Eligibility Breast Cancer NCT00089323

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of invasive adenocarcinoma of the breast diagnosed by core, incisional, or excisional biopsy.
Descripción

Breast adenocarcinoma Invasive Core biopsy | Breast adenocarcinoma Invasive Incisional biopsy | Breast adenocarcinoma Invasive Excisional biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0205281
UMLS CUI [1,3]
C1318309
UMLS CUI [2,1]
C0858252
UMLS CUI [2,2]
C0205281
UMLS CUI [2,3]
C0184922
UMLS CUI [3,1]
C0858252
UMLS CUI [3,2]
C0205281
UMLS CUI [3,3]
C0184921
all of the following staging criteria must be met: primary tumor must be operable and staged as ct1-3 by clinical evaluation. ipsilateral nodes must be cn0-1 by clinical evaluation. no evidence of metastatic disease (m0).
Descripción

Staging criteria Fulfill | Primary tumor Operable TNM clinical staging | Lymph nodes Ipsilateral TNM clinical staging | Neoplasm Metastasis Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332305
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
UMLS CUI [2,1]
C0677930
UMLS CUI [2,2]
C0205188
UMLS CUI [2,3]
C3258246
UMLS CUI [3,1]
C0024204
UMLS CUI [3,2]
C0441989
UMLS CUI [3,3]
C3258246
UMLS CUI [4,1]
C0027627
UMLS CUI [4,2]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with any history of breast malignancy including dcis (patients with a history of lobular carcinoma in situ (lcis) are eligible).
Descripción

Malignant neoplasm of breast | Noninfiltrating Intraductal Carcinoma | Lobular carcinoma in situ of breast eligible

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006142
UMLS CUI [2]
C0007124
UMLS CUI [3,1]
C0279563
UMLS CUI [3,2]
C1548635
treatment including radiation therapy, chemotherapy, and/or hormonal therapy administered for the currently diagnosed breast cancer prior to study entry. the only exception is hormonal therapy, which may have been given for up to a total of 28 days after diagnosis and before study entry.
Descripción

Therapeutic radiology procedure Breast Carcinoma | Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C0279025
UMLS CUI [3,2]
C0678222
patients who will be receiving preoperative chemotherapy.
Descripción

Preoperative Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347669
bilateral malignancy (including dcis).
Descripción

Bilateral Malignant Neoplasm | Noninfiltrating Intraductal Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677861
UMLS CUI [2]
C0007124
other non-breast malignancies unless the patient is considered disease-free for 5 years before study entry and is deemed by their physician to be at low risk for recurrence. patients with the following cancers are eligible if diagnosed and treated within the past 5 years: carcinoma in situ of the cervix, melanoma in situ, colon carcinoma in situ, and basal cell and squamous cell carcinoma of the skin.
Descripción

Malignant Neoplasms Except Malignant neoplasm of breast | Exception Disease Free of | Exception Low Risk Recurrence | Carcinoma in situ of uterine cervix Treated eligible | Malignant melanoma in situ Treated eligible | Colon Carcinoma In situ Treated eligible | Basal cell carcinoma Treated eligible | Squamous cell carcinoma of skin Treated eligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0006142
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0332296
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C3538919
UMLS CUI [3,3]
C0679254
UMLS CUI [4,1]
C0851140
UMLS CUI [4,2]
C1522326
UMLS CUI [4,3]
C1548635
UMLS CUI [5,1]
C0854696
UMLS CUI [5,2]
C1522326
UMLS CUI [5,3]
C1548635
UMLS CUI [6,1]
C0699790
UMLS CUI [6,2]
C0444498
UMLS CUI [6,3]
C1522326
UMLS CUI [6,4]
C1548635
UMLS CUI [7,1]
C0007117
UMLS CUI [7,2]
C1522326
UMLS CUI [7,3]
C1548635
UMLS CUI [8,1]
C0553723
UMLS CUI [8,2]
C1522326
UMLS CUI [8,3]
C1548635
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00089323

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma Invasive Core biopsy | Breast adenocarcinoma Invasive Incisional biopsy | Breast adenocarcinoma Invasive Excisional biopsy
Item
histologic diagnosis of invasive adenocarcinoma of the breast diagnosed by core, incisional, or excisional biopsy.
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C1318309 (UMLS CUI [1,3])
C0858252 (UMLS CUI [2,1])
C0205281 (UMLS CUI [2,2])
C0184922 (UMLS CUI [2,3])
C0858252 (UMLS CUI [3,1])
C0205281 (UMLS CUI [3,2])
C0184921 (UMLS CUI [3,3])
Staging criteria Fulfill | Primary tumor Operable TNM clinical staging | Lymph nodes Ipsilateral TNM clinical staging | Neoplasm Metastasis Absent
Item
all of the following staging criteria must be met: primary tumor must be operable and staged as ct1-3 by clinical evaluation. ipsilateral nodes must be cn0-1 by clinical evaluation. no evidence of metastatic disease (m0).
boolean
C0332305 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0677930 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C3258246 (UMLS CUI [2,3])
C0024204 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
C0027627 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
Malignant neoplasm of breast | Noninfiltrating Intraductal Carcinoma | Lobular carcinoma in situ of breast eligible
Item
patients with any history of breast malignancy including dcis (patients with a history of lobular carcinoma in situ (lcis) are eligible).
boolean
C0006142 (UMLS CUI [1])
C0007124 (UMLS CUI [2])
C0279563 (UMLS CUI [3,1])
C1548635 (UMLS CUI [3,2])
Therapeutic radiology procedure Breast Carcinoma | Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma
Item
treatment including radiation therapy, chemotherapy, and/or hormonal therapy administered for the currently diagnosed breast cancer prior to study entry. the only exception is hormonal therapy, which may have been given for up to a total of 28 days after diagnosis and before study entry.
boolean
C1522449 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0279025 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
Preoperative Chemotherapy
Item
patients who will be receiving preoperative chemotherapy.
boolean
C2347669 (UMLS CUI [1])
Bilateral Malignant Neoplasm | Noninfiltrating Intraductal Carcinoma
Item
bilateral malignancy (including dcis).
boolean
C0677861 (UMLS CUI [1])
C0007124 (UMLS CUI [2])
Malignant Neoplasms Except Malignant neoplasm of breast | Exception Disease Free of | Exception Low Risk Recurrence | Carcinoma in situ of uterine cervix Treated eligible | Malignant melanoma in situ Treated eligible | Colon Carcinoma In situ Treated eligible | Basal cell carcinoma Treated eligible | Squamous cell carcinoma of skin Treated eligible
Item
other non-breast malignancies unless the patient is considered disease-free for 5 years before study entry and is deemed by their physician to be at low risk for recurrence. patients with the following cancers are eligible if diagnosed and treated within the past 5 years: carcinoma in situ of the cervix, melanoma in situ, colon carcinoma in situ, and basal cell and squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0006142 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C3538919 (UMLS CUI [3,2])
C0679254 (UMLS CUI [3,3])
C0851140 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C1548635 (UMLS CUI [4,3])
C0854696 (UMLS CUI [5,1])
C1522326 (UMLS CUI [5,2])
C1548635 (UMLS CUI [5,3])
C0699790 (UMLS CUI [6,1])
C0444498 (UMLS CUI [6,2])
C1522326 (UMLS CUI [6,3])
C1548635 (UMLS CUI [6,4])
C0007117 (UMLS CUI [7,1])
C1522326 (UMLS CUI [7,2])
C1548635 (UMLS CUI [7,3])
C0553723 (UMLS CUI [8,1])
C1522326 (UMLS CUI [8,2])
C1548635 (UMLS CUI [8,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial